J&J | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
AbbVie USD 9.34B 1.36B 2025-03
Abbott USD 5.87B 50M 2025-06
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.98B 637M 2025-06
Baxter International USD 861M 155M 2025-03
Bayer EUR 8.11B 2.11B 2025-03
Becton, Dickinson and Co. USD 2.26B 22M 2025-03
Biogen USD 2.04B 238.8M 2025-06
Boston Scientific USD 3.42B 228M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
CONMED USD 188.32M 7.16M 2025-06
Cooper Companies USD 679.1M 18.9M 2025-04
Dexcom USD 688.8M 99.8M 2025-06
Edwards Lifesciences USD 1.19B 76.7M 2025-06
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.82B 229M 2025-06
Globus Medical USD 402.72M 8.87M 2025-03
Hologic USD 576.6M 15.9M 2025-06
Insulet USD 409M 21.9M 2025-03
Integra LifeSciences USD 209.33M 5.81M 2025-06
Intuitive Surgical USD 1.62B 160.2M 2025-06
J&J USD 14.6B 816M 2025-03
Medtronic USD 5.81B 296M 2025-04
Merck USD 12.99B 224M 2025-06
Merit Medical Systems USD 184.49M 12.47M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Stryker USD 3.81B 385M 2025-03
Tandem Diabetes Care USD 118.41M 39.05M 2025-03
Teva Pharmaceutical Industries USD 2.1B 188M 2025-06
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12
Zoetis USD 1.6B 12M 2025-03


J&J Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.